Parnell
Parnell is a company. It is in Alexandria, Australia and it has a male CEO called Brad R. McCarthy. It was founded in 2009 and is part of the Health Care sector, specifically in the Pharmaceuticals industry.
Key facts
- city: Alexandria
- state: NSW
- country: Australia
- employees: Try Pro to see estimate
- revenues: 23.2M $
- sector: Health Care
- industry: Pharmaceuticals
- foundation year: 2009
- CEO: Brad R. McCarthy
- CEO gender: male
- CEO approval: 49 %
- ESG score: Try Pro to see estimate
Extract data
Download datasets about Parnell:
Stocks from Parnell:
Parnell is one of the companies in Brad R. McCarthy, companies in Australia, companies in Pharmaceuticals, companies in Health Care and 3,584,319 companies in our database.
Talking Points
- ParnellVeterinary Pharmaceuticals for Livestock and Pets
- Parnell discovers, develops, and delivers the best veterinary pharmaceutical solutions for livestock and pets.
- Parnell's mission is to discover, develop, and deliver the best veterinary pharmaceutical solutions. | Over the last fifty years ...
- Parnell Pharmaceuticals Holdings Ltd, a commercial-stage pharmaceutical company, focuses on developing, manufacturing, and marketing animal pharmaceutical products worldwide. The company operates through four segments: Companion Animal, Production Animal - U.S., Production Animal - Rest of World, and Manufacturing Operations. It markets various products, including estroPLAN and GONAbreed reproductive hormone products for enhancing cattle breeding performance; Zydax for the treatment of osteoarthritis (OA) in dogs and horses; and Glyde, a nutraceutical product for the treatment of OA, as well as Parnell PROcept, which adds an additional injection of estroPLAN after the first injection. The company also offers mySYNCH, a digital tool to help veterinarians and producers optimize reproduction and maximize economic gains. Parnell Pharmaceuticals Holdings Ltd was incorporated in 2009 and is headquartered in Alexandria, Australia.